-+ 0.00%
-+ 0.00%
-+ 0.00%

*Rocket Pharma: FDA Alignment Establishes Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease >RCKT

Dow Jones·11/12/2026 21:04:00

Please log in to view news